This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BACKGROUND:Prior clinical trials have demonstrated the efficacy of ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk pulmonary embolism (PE) using reduced thrombolytic doses and shorter infusion durations. Circulation: Cardiovascular Interventions, Ahead of Print. mg, with 31.0%
Prespecified outcomes included modified Rankin scale (mRS) scores, EuroQol Visual Analogue Scale (EQ-VAS), and EQ-5D 3 level version (EQ-5D-3L, composite and individual components) at 30, 180, and 365 days post-ICH.
Background:Mechanical thrombectomy (MT) as treatment for acute ischemic stroke (AIS) has demonstrated superior functional outcomes compared to intravenous thrombolysis (IVT). Healthcare providers should screen for these post-stroke sequelae, which substantially affect quality of life for AIS survivors.
Quality of life at 90 days post-randomization was assessed using EQ-5D-5L. This study aims to derive utility weights for UW-mRS by directly mapping 5-item EuroQoL (EQ-5D-5L) responses to mRS scores.Methods:Data were collected from all patients included in Alteplase compared to Tenecteplase (AcT) trial.
Introduction:Late complications after stroke (LCAS), including cognitive symptoms, impact quality of life and recovery. Stroke, Volume 56, Issue Suppl_1 , Page AHUP15-AHUP15, February 1, 2025. It is not known if neighborhood-level measures of socioeconomic status (SES) influence LCAS.
90-day outcomes were functional status via the average of the 22-item ADL/IADL Scale, post-stroke depression symptoms via the PHQ-8, and quality-of-life via the average of the Stroke Specific QoL Scale (SS-QOL). The census-derived nSES index was our exposure.
90-day outcomes were functional status via the average of the 22-item ADL/IADL Scale, post-stroke depression symptoms via the PHQ-8, and quality-of-life via the average of the Stroke Specific QoL Scale (SS-QOL). The census-derived nSES index was our exposure.
For medical professionals, understanding the latest in stroke recognition and management is paramount to improving patient survival rates and quality of life post-stroke. Advances in Stroke Prevention and Management Modern advancements in stroke prevention and treatment are providing new hope in the fight against this silent killer.
Previously, we have shown that long-term white matter microstructure damage, iron deposition and atrophy within/remote to the 24-hour stroke lesion could influence long term quality of life. Results:We included 24 patients with a 24-hour and long-term MRI protocol.
BACKGROUND:Recent evidence from thrombolysis trials indicates the noninferiority of intravenous tenecteplase to intravenous alteplase with respect to good functional outcomes in patients with acute stroke. There was a strong association (r, 0.85 [95% CI, 0.81–0.89]) 0.49]) and EQ5D VAS scores (r, 0.42 [95% CI, 0.37–0.46]).CONCLUSIONS:Although
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
75 
Let's personalize your content